Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AAAND58082
Magnésium Glycinate 60 Gélules 300mg
midtail
3P
COMPLEMENTS ALIMENTAIRES - THE INFUSION
Last 4 weeks demand
0
≈ stable (0.0% vs prev 4w)
Year-over-year
-100.0%
vs same 4w last year (37 units)
Current stock
100
≈ 32.6 weeks of cover
Unit price
MAD 125
avg of last 30 sells · latest 2026-04-08
AAAND58082
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-06-08 · Total forecast: 118 units.
Actual
Forecast p50 (expected)
Forecast p95 (upper bound)
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Magnésium Glycinate 60 Gélules 300mg · in the midtail cohort · last 4 weeks 0 units, stable demand · on-hand 100 units
Signals the model saw
- Cohort: midtail (483 days of history, 59 units sold over 52 weeks)
- Volatility (CV): 0.85 — moderate
- Recent trend: last 4w = 0 units · prev 4w = 0 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic (p50) — next week | 1.0 units |
| Realistic (p50) — next 4 weeks | 5.8 units |
| Realistic (p50) — next 3 months | 25.2 units |
| Optimistic (p95) — next week | 5.1 units |
| Optimistic (p95) — next 4 weeks (reorder target) | 26.5 units |
| Optimistic (p95) — next 3 months (quarterly PO target) | 117.8 units |
| Legacy μ/wk (reorder pipeline) | 1.9 |
| Revenue exposure — optimistic, 3 months | MAD 14.7K |